Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Shiwen

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
European Journal of Clinical Investigation|April 2, 2009
Endothelin receptor selectivity: evidence from in vitro and pre-clinical models of sclerodermaX Shiwen, A Leask, D J Abraham, et al.
Cardiology Research and Practice|March 31, 2012
Stromal-Cell-Derived Factor-1 (SDF-1)/CXCL12 as Potential Target of Therapeutic Angiogenesis in Critical Leg IschaemiaTeik K Ho, X Shiwen, D Abraham, et al.
The Journal of Biological Chemistry|May 16, 2000
Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblastsD J Abraham, X Shiwen, C M Black, et al.
Molecular Pathology : MP|May 29, 2001
The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblastsA Leask, S Sa, A Holmes, et al.
The Journal of Biological Chemistry|January 21, 2001
CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signalingA Holmes, D J Abraham, S Sa, et al.
Rheumatology (Oxford, England)|October 3, 2008
Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layerN Aden, X Shiwen, D Aden, et al.
Arthritis and Rheumatism|March 27, 2001
Activation of a fibroblast-specific enhancer of the proalpha2(I) collagen gene in tight-skin miceC P Denton, B Zheng, X Shiwen, et al.
British Journal of Rheumatology|November 1, 1995
Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosisC P Denton, M C Bickerstaff, X Shiwen, et al.
The Journal of Clinical Investigation|July 18, 2001
Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patientsR Stratton, X Shiwen, G Martini, et al.
Annals of the Rheumatic Diseases|September 11, 2008
An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosisC P Denton, M Engelhart, N Tvede, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
European Journal of Clinical Investigation|April 2, 2009
Endothelin receptor selectivity: evidence from in vitro and pre-clinical models of sclerodermaX Shiwen, A Leask, D J Abraham, et al.
Cardiology Research and Practice|March 31, 2012
Stromal-Cell-Derived Factor-1 (SDF-1)/CXCL12 as Potential Target of Therapeutic Angiogenesis in Critical Leg IschaemiaTeik K Ho, X Shiwen, D Abraham, et al.
The Journal of Biological Chemistry|May 16, 2000
Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblastsD J Abraham, X Shiwen, C M Black, et al.
Molecular Pathology : MP|May 29, 2001
The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblastsA Leask, S Sa, A Holmes, et al.
The Journal of Biological Chemistry|January 21, 2001
CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signalingA Holmes, D J Abraham, S Sa, et al.
Rheumatology (Oxford, England)|October 3, 2008
Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layerN Aden, X Shiwen, D Aden, et al.
Arthritis and Rheumatism|March 27, 2001
Activation of a fibroblast-specific enhancer of the proalpha2(I) collagen gene in tight-skin miceC P Denton, B Zheng, X Shiwen, et al.
British Journal of Rheumatology|November 1, 1995
Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosisC P Denton, M C Bickerstaff, X Shiwen, et al.
The Journal of Clinical Investigation|July 18, 2001
Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patientsR Stratton, X Shiwen, G Martini, et al.
Annals of the Rheumatic Diseases|September 11, 2008
An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosisC P Denton, M Engelhart, N Tvede, et al.
Pageof 1